Simon Pimstone

Dr. Pimstone has served as Chair of the Board since 2020. He previously served as the President and CEO (2003-2021) of Xenon Pharmaceuticals (Nasdaq: XENE). He now serves as Xenon’s Board Chair, Board Chair for Eupraxia Pharmaceuticals (TSX: EPRX) and President and CEO of XYON Health Inc. Dr. Pimstone is a Consultant Physician at the University of British Columbia Hospital, Cardiology Clinic, and holds the position of Clinical Associate Professor at the University of British Columbia, Division of General Internal Medicine. He holds an MBChB from the University of Cape Town, a FRCPC from the University of British Columbia, and a PhD from the University of Amsterdam in cardiovascular genetics.